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ABSTRACT
Objective: Laparoscopic resection of large gastric gastro-
intestinal stromal tumors (GIST) has been controversial.
This generally has been limited to small lesions. We hy-
pothesize that laparoscopic mobilization and resection
using, in some cases, extracorporeal anastomosis of the
gastrointestinal (GI) tract is an oncologically safe alterna-
tive to open surgery even when tumors are large.
Methods: Four patients underwent a laparoscopic ap-
proach for gastric GIST tumors 2 cm at Methodist Dallas
Medical Center over a 6-month period. Patient demo-
graphics, operative findings, postoperative course, and
pathologic characteristics were examined.
Results: The mean age in this patient group was 58 years
(range, 36 to 77). Gastrointestinal bleeding and dyspepsia
were the most common symptoms. Seventy-five percent
of the patients were females. Mean tumor size was 10 cm
(range, 2.5 to 20) with distribution in the stomach as
follows: 75% greater curvature and 25% antrum. Tumors
were removed by wedge, sleeve, and partial gastrecto-
mies. Two of these tumors showed a high grade and the
other 2 a moderate grade of differentiation. The number of
mitoses was 5/50 HPF in all the tumors. No intraopera-
tive spillage occurred in any patients, even with the largest
tumor (20 cm). Importantly, all tumors were excised with
a negative gross and microscopic margin. Average length
of stay was 4 days. No patients required reoperation, and
there were no complications postoperatively.
Conclusion: Minimally invasive assisted approaches may
be an option to treat large GIST tumors. Obeying princi-
ples of minimal touch, no spillage, and obtaining a neg-
ative margin, a safe operation with a laparoscopic ap-
proach is feasible, even in giant tumors. The large size of
diagnosed GIST tumors should not preclude a minimally
invasive approach.
Key Words: GIST, Laparoscopic surgery, Minimally inva-
sive, Tumor.
INTRODUCTION
Gastrointestinal stromal tumors (GIST) are the most com-
mon nonepithelial, mesenchymal neoplasms of the gas-
trointestinal tract. The tumor originates from the interstitial
pacemaker cells of Cajal accounting for less than 3% of all
gastrointestinal neoplasms.1,3,10 These tumors were re-
ported for the first time in 1983 as a separate entity from
gastrointestinal smooth muscle and nerve sheath tumors.2
Immunohistochemical studies have shown that up to 94%
of GIST tumors express CD117, a c-kit protein, and 60% to
70% of GIST tumors stain for CD34. Therefore, GIST is
now considered a completely separate entity from leiomy-
oma and leiomyosarcoma.2,4,5,6,15
Gastrointestinal stromal tumors occur mainly in the stom-
ach (40% to 70%) followed by 15% each within the small
and large bowel.6,7 These tumors spread by the hematog-
enous route, with the liver being the most common site of
metastasis.
Endoscopic ultrasound (EUS) can be used to diagnose and
biopsy these lesions.5,12 Tumor size 5c ma n d10 mi-
toses/50 high-power field have previously been corre-
lated with a poor outcome.5,8,9,15 However, the presence
of metastatic disease is the only definitive sign of malig-
nancy.
Targeted therapies have been developed for GIST tumors,
but surgical resection remains the optimal first-line ther-
apy.3,6,8,10 Achieving a microscopically free margin ap-
pears to be the key element in surgical therapy, and due
to the pattern of spread, extensive nodal dissection is not
warranted.11 Adjuvant therapy with imatinib (Gleevac), an
agent that targets c-kit, is used in patients with aggressive
Department of General Surgery, Methodist Dallas Medical Center, Dallas, Texas,
USA (Drs Sokolich, Dunn).
Department of Hepatobiliary Surgery, Methodist Dallas Medical Center, Dallas,
Texas, USA (Drs Galanopoulos, Jeyarajah).
Department of Gastroenterology, Methodist Dallas Medical Center, Dallas, Texas,
USA (Dr Linder).
Address correspondence to: D. Rohan Jeyarajah, MD, Director Surgical Oncology
and Upper GI Fellowship Program, 221 West Colorado Blvd, Ste 100, Dallas, TX
75208, USA. Telephone: (214) 943-8605, E-mail: rjeyar@sadtx.com
© 2009 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. Published by
the Society of Laparoendoscopic Surgeons, Inc.
JSLS (2009)13:165–169 165
SCIENTIFIC PAPERtumor characteristics, based on the Fletcher grade classi-
fication for malignant potential.3,9,11,12,13
More recently, minimally invasive approaches have been
shown to be oncologically feasible and safe in other tumor
sites, for example colon cancer as reported by Jacob and
Salky.14 Prior reports have suggested limiting the mini-
mally invasive approach to those gastric GIST tumors that
are 2 cm in size.1,7,15
The purpose of this study was to examine the efficacy of
minimally invasive resection of GIST tumors that are 2
cm. The specific oncologic factors that were examined in
this study were the ability to make the diagnosis of these
gastric tumors by EUS preoperatively, ability to achieve no
spillage during surgery, ability to achieve complete tumor
resection with negative margins, and the ability to perform
safe intestinal anastamosis, if needed.
MATERIALS AND METHODS
A retrospective analysis of 4 patients who underwent
laparoscopic resection of a suspected gastric GIST at
Methodist Dallas Medical Center in 2007 was performed
after receiving Institutional Review Board approval for the
study. All 4 patients had a GIST tumor 2 cm.
Patient demographics, clinical presentation, and anatom-
ical location of the tumors were analyzed. Perioperative
parameters measured included postoperative recovery in-
cluding morbidity, mortality, and length of hospitalization.
Tumor histopathologic characteristics including size, mi-
totic activity, and violation of the pseudocapsule were
also reviewed.
An initial EUS-guided fine-needle aspiration was per-
formed as part of the staging. Suspicion for GIST was
based on endoscopic features, such as an intact mucosa, a
predominantly submucosal location, and in some cases, a
pedunculated appearance.
These patients also underwent a preoperative abdominal
computed tomography (CT) scan as part of their diagnos-
tic workup for assessment of the presence of distant me-
tastases or local tumor invasion. The position of the pa-
tients in the operating room and location of the trocars for
the laparoscopic resection of these tumors are shown in
Figure 1.
Tumors 5 cm and close to the esophagogastric junction
were excluded from laparoscopic wedge resection but
included in indications for laparoscopic operation with a
small laparotomy (so-called laparoscopic-assisted opera-
tion). Distal gastrectomy was used for bulky tumors lo-
cated in the middle or distal third of the stomach and
wedge resection for peripheral gastric tumors (Table 1).
The general principle used during the surgical approach is
described as follows: The lesser sac was opened preserv-
ing the gastroepiploic vessels bilaterally extending up to
the short gastric vessels and distally towards the duode-
num by using a 5-mm Harmonic scalpel. The stomach was
then elevated out of the way by using a self-retaining
retractor through a 5-mm port that was placed in the right
lower quadrant.
These tumors have massive collateral vessels that were
ligated and divided with clips. Once the tumor was re-
leased from the area of the lateral, inferior, and medial
aspect of these collateral vessels, attention was then paid
to the stomach. A window was created underneath the
stomach all the way to the splenic flexure that was mobi-
lized, and the splenic flexure was taken down to mobilize
the colon away from this tumor. We used an Endo GIA
stapler (63.5mm) that was inserted through the umbilical
Figure 1. Demonstrating position of the patient and location of
the trocars.
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allowing the tumor to be freed from the stomach. The only
attachments left on the tumor at this time were in the
posterior aspect.
The pneumoperitoneum was released, and the supraum-
bilical incision was extended for a length of approxi-
mately 6 cm to 7 cm, allowing us to gently deliver this
tumor through the anterior abdominal wall. We ligated the
posterior attachments and some small collateral vessels by
using 5-mm ligature clips and 2–0 silk sutures. At this
point, the tumor was freed and sent to pathology for
frozen section. There was no rupture or spillage of the
tumor or bleeding from the tumor.
RESULTS
Four patients underwent gastric GIST resection in a
6-month period. The mean age in this patient group was
58 (range, 36 to 77). Gastrointestinal bleeding and dys-
pepsia were the most common symptoms. Seventy-five
percent of the patients were females. All patients were
accurately diagnosed preoperatively as having nonmeta-
static GIST by using EUS and CT scan.
Seventy-five percent of tumors were considered to be
GIST by classic ultrasound appearance, and 50% were
biopsy proven gastric GIST tumors at the time of EUS.
Mean tumor size was 10 cm (range, 2.5 to 20) with distri-
bution in the stomach as follows: 75% greater curvature
and 25% antrum. None of these patients received neoad-
juvant therapy.
Two of the 4 gastric GIST tumors were removed by wedge
resection by using a laparoscopic stapler surrounding the
tumor with a margin of normal tissue. The tumor was
removed from the abdominal cavity by using a laparo-
scopic retrieval bag. In the other 2 cases, a partial gastrec-
tomy with extracorporeal anastomosis was performed. We
used the Harmonic scalpel to mobilize the greater curva-
ture of the stomach to the duodenum. The distal stomach
and proximal duodenum were divided to include the
entire tumor. The midline port wound was extended to
remove this specimen with the help of a laparoscopic
retrieval bag. An extracorporeal side-to-side stapled gas-
trojejunostomy was performed. Two of these tumors
showed a high-grade and the other 2 showed a moderate-
grade of differentiation. Lack of violation of the pseudo-
capsule and margin negativity was confirmed in all cases.
The number of mitoses was 5/50 HPF in all the tumors.
There was no intraoperative spillage in any patient, even
with the largest tumor at 20 cm.
Average length of stay was 4 days. No patients required
reoperation, and no postoperative complications oc-
curred. Patients were discharged tolerating a regular diet.
DISCUSSION
We report herein on the efficacy of the minimally invasive
assisted approach for the treatment of large gastric GIST
2 cm. This report suggests that preoperative selection by
EUS followed by a meticulous oncologic operative tech-
nique can result in complete resection of large GIST with
negative margins and no spillage. The guidelines for min-
imally invasive gatstrectomy for GIST should be modified
to include large lesions.
Patients with gastric GIST have better survival than those
with small intestinal GIST as reported by Emory et al.4
Surgical management has been shown to be a critical
factor in their treatment, even in the era of imatinib.
Achieving a negative margin resection with no spillage at
the time of surgery is essential.3,16 The ability to achieve
this status is paramount in choosing patients who might
Table 1.
Endoscopic Ultrasound (EUS) With Preoperative Workup Characteristics and Type of Surgery Performed
EUS Characteristics EUS Suspicious for Gastrointestinal
Stromal Tumors
EUS Biopsy Operation Performed
10-cm mass in the body of stomach,
no vascular invasion
None Negative Distal Gastrectomy
2.5-cm submucosal mass anterior
wall stomach
Yes Positive Wedge Resection
3.6-cm submucosal mass in antrum
of stomach, no invasive patterns
Yes Negative Distal Gastrectomy
14-cm submucosal mass in greater
curvature of stomach
Yes Positive Sleeve Gastrectomy
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utility of EUS has been found to be very helpful in making
this determination, and, in fact, the diagnosis was made by
EUS in 75% of this population. It is the belief of our group
that minimally invasive techniques should not be used for
gastric resections that require nodal dissections (ie, ade-
nocarcinoma). Therefore, preoperative diagnosis is essen-
tial in patient selection. The question of which surgeons
are qualified to perform these minimally invasive resec-
tions is controversial. In fact, a team approach is often the
best approach, because technical laparoscopic skills are
required, as is excellent knowledge of upper gastrointes-
tinal anatomy. Intraoperative endoscopy can be beneficial
for tumors that are close to the esophagus. A detailed
knowledge of tumor biology and the potential role of
neoadjuvant therapy are essential. It is unclear whether
any surgeon could possess all of these skills, and the
alignment of a team might be the best approach.
Surgery is the preferred management for GIST when fea-
sible. There is still debate regarding the most appropriate
operative approach and the extent of resection re-
quired.5,15 The aim of surgery is complete removal of the
tumor with negative resection margins and preservation of
anatomical function.17 However, even microscopically
positive margins may not change overall prognosis, as
demonstrated by DeMatteo et al.16 Unlike adenocarci-
noma, in which submucosal and subserosal lymphatic
spread requiresa5c mt o6c msurgical margin, gastric
GIST tends to grow out of the primary organ instead of
infiltrating the submucosal tissue. Lymph node metastases
are very rare, and routine lymphadenectomy is not re-
quired. Wedge resection of gastric GIST tumors has been
widely reported to be successful.7,13 Also evidence exists
that laparoscopic resection of gastric GIST tumors is ef-
fective with minimal morbidity, and no reported mortality.
With this report, we corroborate the experience of No-
vitsky et al15 who demonstrated that the laparoscopic
approach appears to offer excellent therapeutic outcomes,
with a 92% long-term disease-free survival for gastric GIST
tumors of various sizes (1.0 cm to 8.5 cm).16,17 We would
like to expand the laparoscopic indications for resection
of these large tumors to a size ranging from 2. 5 cm to 20
cm. Yano et al18 have reported the removal of 2 gastric
GIST tumors in the 7 cm to 8 cm diameter range by using
hand-assisted laparoscopic surgery (HALS).
If a laparoscopic approach is contemplated, several fac-
tors including patient characteristics, tumor features (size,
location, invasion), as well as the surgeon’s experience
and expertise, need to be considered. Tumor rupture
during laparoscopy should be avoided, as peritoneal
seeding affects the disease-free period and overall sur-
vival. Resection margins need to be clear in all cases,
confirming the oncological safety of the laparoscopic ap-
proach.
The role of neoadjuvant and adjuvant therapy in GIST has
evolved over the past several years, and imatinib is now
used in patients who display poor prognostic features,
such as large size or mitotic activity.2,8 A neoadjuvant
approach is used selectively in difficult to access surgical
sites.8
The main purpose of this report is to question the size
limits on minimally invasive resection of gastric GIST. This
study has shown that large GIST can be resected safely,
while obeying the cancer principles that are paramount to
treating this disease.
GIST tumors have an unpredictable behavior. Even with
risk stratification, careful follow-up is required. Even
though the majority of GIST tumors are likely to recur
within 2 years after surgery, follow-up beyond this period
would seem sensible.
CONCLUSION
Although more definitive results will require a large-scale,
prospective, randomized trial with longer postoperative
follow-up evaluation, we conclude from this study that
minimally invasive assisted approaches may be an option
to treat large gastric GIST tumors. Obeying principles of
minimal touch, no spill, obtaining a negative margin, and
a safe operation with a laparoscopic approach is feasible,
even in giant tumors. Large size, nonmetastatic gastric
GIST tumors should not preclude a minimally invasive
approach. Long-term follow-up with abdominal tomogra-
phy is necessary.
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